SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST (1490)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-glomerular basement membrane (GBM) antibodies (K011348 | K011348) HIGH
Effective Date: 2001-06-22

Other General Immunology Devices:

Medical DeviceComplexity
IMMCO Diagnostics ImmuLisa Anti-Intrinsic Factor (IF) Antibody ELISAView Complexity
DiaSorin LIAISON AnalyzerView Complexity
TheraTest Laboratories EL-ANA/8 (ssDNA,dsDNA,Sm,RNP/Sm,SSA,SSB,Scl70,H)View Complexity
OLYMPUS REPLYView Complexity
BRAHMS Diagnostica DYNOtest Anti-TgView Complexity
DADE BEHRING BN 100View Complexity
DIAMEDIX MAGO PLUSView Complexity
Becton Dickinson FACSLyric Flow CytometerView Complexity
Roche Diagnostics Elecsys E170 Modular Analytics Immunoassay AnalyzerView Complexity
Siemens Healthcare Diagnostics ADVIA Chemistry XPT SystemView Complexity